Shares of Hyperion DeFi, Inc. (NASDAQ:HYPD - Get Free Report) were up 0.2% during mid-day trading on Thursday . The company traded as high as $13.71 and last traded at $12.28. Approximately 1,451,825 shares changed hands during trading, an increase of 49% from the average daily volume of 977,041 shares. The stock had previously closed at $12.26.
Wall Street Analyst Weigh In
Separately, Wall Street Zen lowered Hyperion DeFi from a "hold" rating to a "sell" rating in a research report on Saturday, July 26th. Four equities research analysts have rated the stock with a Hold rating, Based on data from MarketBeat, Hyperion DeFi presently has an average rating of "Hold" and an average target price of $2.00.
Read Our Latest Research Report on HYPD
Hyperion DeFi Stock Down 8.1%
The company has a market capitalization of $64.18 million, a price-to-earnings ratio of -0.19 and a beta of 2.50. The stock's fifty day moving average price is $8.65 and its 200-day moving average price is $5.24. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.20.
Hyperion DeFi (NASDAQ:HYPD - Get Free Report) last posted its quarterly earnings results on Wednesday, August 13th. The company reported ($2.50) earnings per share (EPS) for the quarter. Hyperion DeFi had a negative return on equity of 876.25% and a negative net margin of 62,238.41%. On average, sell-side analysts predict that Hyperion DeFi, Inc. will post -41.6 earnings per share for the current fiscal year.
Institutional Trading of Hyperion DeFi
An institutional investor recently bought a new position in Hyperion DeFi stock. Virtu Financial LLC acquired a new stake in Hyperion DeFi, Inc. (NASDAQ:HYPD - Free Report) during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 23,065 shares of the company's stock, valued at approximately $25,000. Virtu Financial LLC owned 0.82% of Hyperion DeFi at the end of the most recent reporting period. Hedge funds and other institutional investors own 25.84% of the company's stock.
Hyperion DeFi Company Profile
(
Get Free Report)
Eyenovia, Inc, an ophthalmic technology company, engages in the development of therapeutics based on its proprietary microdose array print platform technology. The company's product candidates include MicroPine, which is in Phase III clinical development program with indications for pediatric myopia progression (near-sightedness); MicroLine, which is in Phase III clinical development program with indications for the improvement in near vision in people with presbyopia; and Mydcombi, which is in Phase III clinical development program with indications for pharmaceutical mydriasis.
Recommended Stories
Before you consider Hyperion DeFi, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hyperion DeFi wasn't on the list.
While Hyperion DeFi currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.